Key result
In patients with moderate chronic kidney disease, coexisting type 2 diabetes did not significantly worsen left ventricular diastolic dysfunction, with similar EmLV values (7.4 vs 7.6 cm/s; P=0.723).
Why the study?
Does coexisting type 2 diabetes worsen left ventricular diastolic dysfunction in patients with moderate chronic kidney disease?
Cross-Sectional (n=58)
Does coexisting type 2 diabetes worsen left ventricular diastolic dysfunction in patients with moderate chronic kidney disease?
Absolute Event Rate: 7.4% vs 7.6%
p-value: p=0.723
In patients with moderate chronic kidney disease, the coexistence of type 2 diabetes does not significantly worsen left ventricular diastolic dysfunction.
Supports equivalent diastolic monitoring in moderate CKD regardless of diabetes; leaves open prospective assessment of progression and outcomes.
Patients with chronic kidney disease (CKD) and coexisting diabetes mellitus (DM) are likely to have cardiological complications. We assessed whether patients with moderate kidney dysfunction, with coexisting type 2 DM and preserved left ventricular (LV) systolic function, demonstrate a more advanced LV diastolic dysfunction. The study group consisted of 58 ambulatory patients with CKD, stages 3 and 4. The patients were assigned to groups based on the presence of type 2 DM. The first group (DM+) consisted of 21 patients with type 2 DM while second one (DM−) consisted of 37 patients without type 2 DM. Standard echocardiography was performed in all patients with tissue Doppler echocardiography for evaluation of the systolic velocity and both diastolic velocities of LV. The following laboratory parameters were measured: serum creatinine concentration, estimated glomerular filtration rate, and the levels of urea, phosphorus, calcium, parathormone, platelets count, hemoglobin level and N-terminal pro-B-type natriuretic peptide levels. LV diastolic dysfunction was defined as EmLV less than 8 cm/s. Patients in DM+ group, as compared to patients in DM− group, were characterized by higher values of left and right ventricular end-diastolic dimension, left atrial diastolic dimension, interventricular septal diastolic diameter, LV posterior wall dimension at diastole and of LV mass index, smaller LV ejection fraction and LV fractional shortening. In tissue Doppler echocardiography patients of DM+ group, as compared to patients of DM− group, did not differ in value of EmLV (7.4 ± 2.4 cm/s vs. 7.6 ± 2.1 cm/s, P = .723), respectively, and were characterized by similar estimated LV diastolic filling pressure as indicated by E/EmLV (10.1 ± 3.7 vs. 8.8 ± 2.6, P = .119). CKD patients in the moderate stage, with coexisting type 2 DM were not characterized by higher risk of developing LV diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Gromadziński et al. (2014) conducted a cross-sectional in Chronic kidney disease stages 3 and 4 (n=58). Type 2 diabetes mellitus vs. No type 2 diabetes mellitus was evaluated on EmLV (left ventricular diastolic dysfunction) (p=0.723). In patients with moderate chronic kidney disease, coexisting type 2 diabetes did not significantly worsen left ventricular diastolic dysfunction, with similar EmLV values (7.4 vs 7.6 cm/s; P=0.723).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: